Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Getinge AB

Market Cap 53.52B 5.71B 4.92B 4.53B 4.25B 7.98B 539B 8.06B 20.91B 264B 21.42B 20.96B 914B P/E Ratio 2026 *
18.9x
P/E Ratio 2027 * 16.1x
Enterprise Value 61.93B 6.6B 5.69B 5.24B 4.91B 9.23B 624B 9.32B 24.19B 306B 24.78B 24.26B 1,058B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.63x
Free-Float
78.61%
Yield 2026 *
2.57%
Yield 2027 * 2.79%
1 day-13.69%
3 months-13.69%
6 months-4.52%
Current year-9.28%
Current year 20.05
Extreme 20.05
24.75
1 year 18.82
Extreme 18.82
24.75
3 years 15.62
Extreme 15.62
24.75
5 years 15.62
Extreme 15.62
48.01
10 years 8.75
Extreme 8.75
48.01
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO - 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Director/Board Member 70 01/01/2007
Chairman 75 -
Chairman 65 23/04/2019
Change 5-day change 1-year change 3-year change Capi.($)
-13.69%-.--% - - 5.69B
-0.35%-0.59%+21.92%-5.94% 12.54B
-2.23%-5.78%+51.91%+24.42% 6.02B
+0.20%+1.92%-28.92%+19.20% 4.28B
-0.07%+3.36% - - 4.26B
+0.73%+0.89%-27.08%-22.29% 3.83B
-1.04%+4.90%-1.28%-59.74% 2.06B
+5.83%+12.18%+52.72%+220.35% 1.76B
-1.00%-2.13%+56.86%-5.39% 1.56B
+0.99%-6.51%-11.57%-49.05% 1.31B
Average -0.94%+2.06%+14.32%+15.20% 4.18B
Weighted average by Cap. -1.81%+1.38%+15.70%+7.82%

Financials

2026 *2027 *
Net sales 34.91B 3.72B 3.21B 2.95B 2.77B 5.2B 352B 5.26B 13.64B 172B 13.97B 13.67B 596B 36.63B 3.91B 3.37B 3.1B 2.91B 5.46B 369B 5.51B 14.31B 181B 14.66B 14.35B 626B
Net income 2.81B 300M 258M 238M 223M 419M 28.32B 423M 1.1B 13.87B 1.12B 1.1B 47.99B 3.31B 353M 304M 280M 263M 494M 33.38B 499M 1.29B 16.35B 1.33B 1.3B 56.57B
Net Debt 8.41B 897M 773M 712M 667M 1.25B 84.77B 1.27B 3.29B 41.51B 3.37B 3.29B 144B 6.32B 674M 581M 535M 502M 942M 63.7B 952M 2.47B 31.19B 2.53B 2.48B 108B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,754
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
196.25SEK
Average target price
227.20SEK
Spread / Average Target
+15.77%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!